Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Finasteride modifies 5-alpha-reductases through a two-step process, affecting inhibitor potency and possibly causing side effects.

The combination of encorafenib and binimetinib caused few skin issues.

SPET-085 effectively inhibits an enzyme linked to prostate issues, similar to finasteride.

Oral and topical tofacitinib can help regrow hair in people with severe alopecia areata.

Finasteride may help reduce COVID-19 infection by altering a key gene.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

Early diagnosis and quick treatment improve life quality for FFA patients.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

Transethosomal gels improve naftifine skin delivery better than Exoderil cream.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Tofacitinib shows promise for treating alopecia areata with significant hair regrowth and mild side effects.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Ustekinumab treatment didn't prevent frontal fibrosing alopecia.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.

Special nanoparticles increased skin absorption of hair loss treatments with fewer side effects.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

A balanced approach using dutasteride and Serenoa repens can improve hair transplant success by protecting follicles and minimizing side effects.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

SARMs show promise but need more evidence to prove they're better than traditional androgens.